Literature DB >> 11056349

Impact of activation of MAP kinase family members on endocrine response and survival in clinical breast cancer

.   

Abstract

Year:  2000        PMID： 11056349     DOI： 10.1016/s0959-8049(00)00259-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.

Authors:  Suleiman Massarweh; Jessica Moss; Chi Wang; Edward Romond; Stacey Slone; Heidi Weiss; Rouzan G Karabakhtsian; Dana Napier; Esther P Black
Journal:  Future Oncol       Date:  2014-12       Impact factor: 3.404
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.